Resources
3 Results (showing 1 - 3)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 12/9/2020 (updated 4/3/2024)
State policymakers are interested in learning about the most effective treatments to address OUD and avoid unintended consequences such as overdose events, mortality from overdose, and use of illicit and unregulated drugs. This article describes the lack of evidence surrounding the use of Medically Supervised Withdrawal as a standalone “treatment.”
Posted 6/6/2022 (updated 3/27/2024)
This session highlighted over a decade of Community Apgar research and its implementation supporting community development for physician recruitment and retention in rural FQHCs and CAHs. This presentation also included ongoing implementation of the program through collaboration with 3RNet and the use of a “Factors Book” which can highlight community assets and focus recruitment efforts to better meet community needs.
Posted 3/15/2022 (updated 3/27/2024)
This TIP reviews three Food and Drug Administration-approved medications for opioid use disorder treatment—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support people in recovery.